Drug and Medical Device Development: A Strategic Approach
Front load your knowledge to achieve commercial success.
Drug and Medical Device Development: A Strategic Approach | MIT xPRO
- START DATE March 6, 2025 More Dates
- TIME COMMITMENT 5-6 hours/week
- DURATION 8 weeks including orientation
- FORMAT Online
- CEUs 4
- PRICE $3,500
Digital disruption in healthcare has created an opportunity for new products that are data-driven and patient-centered. The market volume of medical technology by 2026 is estimated to reach USD 644.2 billion (Source: Statista). However, bringing a medical device or drug to market is very different from building other kinds of products. Strict regulation also makes it a highly complex process. The MIT xPRO Drug and Medical Device Development: A Strategic Approach program is designed to provide you with a big picture view of initiating a medical drug or product development. It will also help you anticipate and address the complexities involved with developing medical products.
WHAT YOU WILL LEARN
MIT xPRO is collaborating with online education provider Emeritus to deliver this online program. By clicking LEARN MORE, you will be taken to a page where you can download the brochure and apply to the program via Emeritus.
- Gain a “big picture” perspective of the entire drug and medical device development process, from day one strategic planning through product commercialization
- Understand the critical interplay between strategy and development—and how they affect each other
- Learn frameworks for assessing both the benefits and the risks associated with developing a new product in the healthcare market
- Gain clarity around the regulatory requirements in the U.S. market and the process for achieving approval
- Develop professional networks for career development, industry partnerships or strategic alliances
WHO SHOULD ENROLL
- Engineers involved in the development of new medical device products or pharmaceuticals
- Executives in the drug and medical device development/product management field
- Scientists and those who lead teams of scientists in R&D
- Quality assurance and regulatory affairs professionals
- Professionals making a horizontal transition into the healthcare industry
- Entrepreneurs seeking to launch a product in the U.S. healthcare market
- Having a background in health sciences is helpful but not required.